Document is current

Article History

Received: 20 December 2024

Accepted: 29 April 2025

First Online: 4 June 2025

Declarations

:

: The authors whose names are listed immediately below report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript. Ninomiya K reports honoraria outside the current work from AstraZeneca, Amgen, MSD, Elekta, Ono Pharmaceutical, Guardant Health, Kyowa Kirin, CareNet, Daiichi Sankyo, Taiho Pharmaceutical, Takeda Pharmaceutical, Chugai Pharmaceutical, Lilly, Nippon Kayaku, Boehringer Ingelheim, Novartis, Pfizer, Bristol Myers Squibb, Janssen Pharmaceutical. Kunimasa K reports honoraria outside the current work from Chugai Pharamaceutical. Yuki S reports honoraria outside the current work from AstraZeneca, MSD, Novartis, Chugai Pharmaceutical, Ono Pharmaceutical, Pfizer, Taiho Pharmaceutical, Nippon Kayaku, Bristol Myers Squibb, Eli Lilly, Takeda, Kyowa Kirin, Daiichi Sankyo, Boehringer Ingelheim. Yuki S also reports travel expenses from Regeneron Pharmaceuticals. Hotta K reports honoraria outside the current work from AstraZeneca, Chugai Pharmaceutical, Lilly, MSD, Bristol Myers Squibb, Ono Pharmaceutical, Boehringer Ingelheim, Nippon Kayaku, Amgen, Taiho Pharmaceutical, Merck. Hotta K also reports research fund outside the current work from MSD, AstraZeneca, Chugai Pharmaceutical, Lilly, Bristol Myers Squibb, Abbvie, Ono Pharmaceutical. All the other authors declare no conflicts of interest regarding this study.